|
 
 |
| LETTER TO EDITOR |
|
| Year : 2022 | Volume
: 12
| Issue : 2 | Page : 94-96 |
|
Zinc and mucormycosis – Fact versus myth check
Shibu Sasidharan1, Harpreet Singh Dhillon2
1 Department of Anaesthesia and Critical Care, Level III IFH Hospital, Goma, Democratic Republic of the Congo
2 Department of Psychiatry, Level III IFH Hospital, Goma, Democratic Republic of the Congo
| Date of Submission | 28-Sep-2021 |
| Date of Decision | 12-Feb-2022 |
| Date of Acceptance | 30-Mar-2022 |
| Date of Web Publication | 26-Apr-2022 |
Correspondence Address:
Dr. Shibu Sasidharan
Department of Anaesthesia and Critical Care, Level III IFH Hospital, Goma
Democratic Republic of the Congo
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/cmrp.cmrp_97_21
How to cite this article:
Sasidharan S, Dhillon HS. Zinc and mucormycosis – Fact versus myth check. Curr Med Res Pract 2022;12:94-6 |
Dear Editor,
As on 12 June, 2021, coronavirus disease 2019 (COVID-19) has totalled 176,104,156 cases with 3,802,165 deaths worldwide. In India, there have been 367,097 deaths so far.[1]
India's second wave of COVID-19 turned out to be much more deadly than the milder first wave. Large crowds, political rallies, religious gatherings and compact urban spaces were named the driving reason for the uncontrolled spread of infection. Researches have also pinned the blame on the new variant of the virus which was first discovered in India (B.1.617.2), which was assigned the name 'Delta' by the WHO, for this alarming transmission.[2]
Before vaccines were available, there was a raging demand for Vitamin C, D and zinc supplements as immunity boosters, which people thought would supercharge their immunity and give them the protection they need to deter the second wave of COVID-19. Zinc and Vitamin D apparently helped former US President Donald Trump in his recovery when he was infected in October 2020.[3] Data available on the Internet (infodemic), especially in the pandemic, can be hugely misleading.[4]
The mechanism of multivitamins in the body is to build immunity and act as antioxidants, but there is not enough evidence to link its use and prevention of COVID-19.[5] We should have accurate data of Phase 1 and 2 before a Phase 3 administration is done in large populations of people. Thus, we should exercise caution in moving forward with the supplementation drive. Although supplements are generally thought of as benign, their excess use is not free from adverse effects.
As the COVID-19 wave ravaged the country, there emerged a new challenge in the form of mucormycosis. Mucormycosis (formerly termed zygomycosis) is a lethal but relatively rare fungal infection which is caused by a collection of moulds that live throughout the environment called mucormycetes. This disease mainly affects people with comorbidities and those with an obtunded immunity. It usually affects the lungs and sinuses after fungal spores are inhaled from the air we breathe.[6] On 20 May, 2021, the Union health ministry of India urged the States and Union territories to make mucormycosis a notifiable disease under the Epidemic Diseases Act, 1897.[7]
Over the past few months, India has reported over 28,200 cases of Mucor.[8] There are various hypotheses making rounds. Some suggest the use of iron, while others blame the failure to use sterile water in oxygen concentrators to this outbreak. The reuse of masks and cannulas is another theory. However, does zinc cause/add to the chances of developing mucormycosis?
The fungal cells need zinc for their proper development, even as saprophytes or during the infection process. As a defence mechanism, to halt the growth of pathogen, host animals usually reduce the levels of metals like zinc, making them unavailable to the pathogen.[9] This is called as 'nutritional immunity'[10] where the host aggressively interrupts and counters metal uptake by microorganisms.[11]
This is done by various mechanisms.
- There is a pH-dependency of zinc uptake. The host's near-neutral pH lowers zinc solubility and reduces its accessibility to microorganisms[10]
- Intracellularly, stimulated T-cells, macrophages and dendritic cells decrease their lysosomal zinc content through the expression of the zinc transporter ZIP8, inducing zinc limitation for pathogens in the phagolysosome[12]
- Stimulated dendritic cells reduce their cytoplasmic zinc concentration by upregulating zinc exporters and downregulating zinc importers[13]
- By binding to the metallothioneins (MTs) and by sequestering labile zinc, cytokine-activated macrophages restrict the intracellular growth of fungi[14]
- The host protein calprotectin inhibits bacterial and fungal growth by chelating transition metals, including zinc.[15],[16]
In human tissues and fluids, the concentration of zinc varies dramatically (body fluids – 0.2 to 8.7 μ g/mL, lungs – 10 μ g/g and liver – 83.2 μ g/g).[17] These pathogenic fungi to overcome the limits set by the host have developed various operative strategies to uptake zinc.[18] The fungi primarily use the ZIP family transporters (e.g. Zrt1 and Zrt2) for aiding the zinc transport into the cytoplasm across cellular membranes. Other fungal species also use additional mechanisms to confiscate zinc from host cells and tissues. This is a process very similar to iron chelation. Candida albicans, for example, secretes Pra1 (its antigenic protein), a zinc-binding protein to scavenge zinc from fungus invaded tissues. Zrt3 is a ZIP transporter found in the membranes of zincosomes (vacuoles that accumulate zinc) and supplies zinc to the cytoplasm from zincosomes.[18]
This active mechanism of zinc deprivation by mammalian hosts against fungal infection (by the activity of the host zinc transporters or the expression of zinc-binding proteins) is compromised with the excess intake of zinc, which provides the deficient pathogen with the zinc supply it needs to regulate the expression of many proteins which is required for infection.
Laboratory studies have already proven that zinc chelation can reduce fungal growth in both rich and defined media.[15]
An excess of zinc can, however, also be toxic for cell. This is because of the fact that zinc does not participate in Fenton chemistry.[19] This is mainly due to a competition with other metals for metal-binding sites in enzymes.[20]
Although scientifically, the easy availability of zinc through multivitamin tablets aids molecular mechanisms of pathogenic microorganisms to circumvent host metal restriction and provides a fertile ground for expression, however, for associating mucormycosis with zinc supplementation, we need more data to ascertain a direct cause–effect relationship.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | |  |
| 1. | |
| 2. | |
| 3. | |
| 4. | Sasidharan S, Harpreet Singh D, Vijay S, Manalikuzhiyil B. COVID-19: Pan (info) demic. Turk J Anaesthesiol Reanim 2020;48:438-42.  |
| 5. | Michos ED, Cainzos-Achirica M. Supplements for the treatment of mild COVID-19 – Challenging health beliefs with science from A to Z. JAMA Network Open Am Med Assoc 2021;4:e210431. |
| 6. | |
| 7. | |
| 8. | |
| 9. | |
| 10. | Gerwien F, Skrahina V, Kasper L, Hube B, Brunke S. Metals in fungal virulence. FEMS Microbiol Rev 2018;42:1-21. |
| 11. | |
| 12. | Begum NA, Kobayashi M, Moriwaki Y, Matsumoto M, Toyoshima K, Seya T. Mycobacterium bovis BCG cell wall and lipopolysaccharide induce a novel gene, BIGM103, encoding a 7-TM protein: Identification of a new protein family having Zn-transporter and Zn-metalloprotease signatures. Genomics 2002;80:630-45. |
| 13. | Kitamura H, Morikawa H, Kamon H, Iguchi M, Hojyo S, Fukada T, et al. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat Immunol 2006;7:971-7. |
| 14. | SubramanianVignesh K, LanderoFigueroa JA, Porollo A, Caruso JA, Deepe GS. Granulocyte macrophage-colony stimulating factor induced Zn sequestration enhances macrophage superoxide and limits intracellular pathogen survival. Immunity 2013;39:697-710. |
| 15. | Lulloff SJ, Hahn BL, Sohnle PG. Fungal susceptibility to zinc deprivation. J Lab Clin Med 2004;144:208-14. |
| 16. | Corbin BD, Seeley EH, Raab A, Feldmann J, Miller MR, Torres VJ, et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 2008;319:962-5. |
| 17. | Lech T, Sadlik JK. Zinc in postmortem body tissues and fluids. Biol Trace Elem Res 2011;142:11-7. |
| 18. | Staats CC, Kmetzsch L, Schrank A, Vainstein MH. Fungal zinc metabolism and its connections to virulence. Front Cell Infect Microbiol 2013;3:65. |
| 19. | Prousek J. Fenton chemistry in biology and medicine. Pure Appl Chem 2007;79:2325-38. |
| 20. | McDevitt CA, Ogunniyi AD, Valkov E, Lawrence MC, Kobe B, McEwan AG, et al. A molecular mechanism for bacterial susceptibility to Zinc. PLoS Pathog 2011;7:1002357. |
|
Search Pubmed for